Initiation and progression of cancer involve multiple molecular mechanisms. The knowledge on these mechanisms is expanding and should be converted into guidelines for tackling the disease. We discuss here formalization of biological knowledge into a comprehensive resource Atlas of Cancer Signalling Network (ACSN) and Google Maps-based tool NaviCell that supports map navigation. The application of maps for omics data visualisation in the context of signalling maps is possible using NaviCell Web Service module and NaviCom tool for generation of network-based molecular portraits of cancer using multi-level omics data. We review how these resources and tools are applied for cancer pre-clinical studies among others for rationalizing synergistic effect of drugs and designing complex disease stage-specific druggable interventions following structural analysis of the maps together with omics data. Modules and maps of ACSN as signatures of biological functions, can help in cancer data analysis and interpretation. In addition, they can also be used to find association between perturbations in particular molecular mechanisms to the risk of a specific cancer type development. These approaches and beyond help to study interplay between molecular mechanisms of cancer, deciphering how gene interactions govern hallmarks of cancer in specific context. We discuss a perspective to develop a flexible methodology and a pipeline to enable systematic omics data analysis in the context of signalling network maps, for stratifying patients and suggesting interventions points and drug repositioning in cancer and other human diseases.
Introduction
According to the current understanding, signalling pathways create a complex network with forward and backward regulatory loops, and many redundant pathways. The basic assumption is that during a pathological transformation cells do not create new signalling mechanisms, but rather hijack the existing molecular programs. This not only affects intracellular functions, but also the interactions between different cell types, leading to a new, yet pathological status of the system. There is a certain combination of molecular characteristics dictating specific cell signalling states enduring the pathological disease status. Identifying and manipulating the key molecular players controlling these cell signalling states, and shifting the pathological status toward the desired healthy phenotype are The scheme demonstrates the concept of ACSN construction starting from the cancer hallmarks: collecting information about molecular mechanisms underlying those hallmarks from scientific publications and manually depicting them in the global map of ACSN and further supporting by consulting the information from the external pathway databases. ACSN is hierarchically organized into three levels: the seamless global map divided into the interconnected biological process maps that are further decomposed into interconnected module maps. ACSN can be exploited through web-based NaviCell interface allowing map navigation using Google Maps engine, map commenting via associated blog system and user omics data visualisation and analysis (Adapted from [12] ) .
The construction and update of ACSN involve manual mining of molecular biology literature along with the participation of experts in those fields. ACSN differs from other databases because it contains a deep comprehensive description of cancer-related mechanisms retrieved from the most recent literature, following the hallmarks of cancer ( Figure 1 ). Cell signalling mechanisms are depicted using the CellDesigner tool [13] at the level of biochemical interactions, assembling a large network of 4826 reactions covering 2371 proteins and based on approximately 3000 references ( Table 1) . presented as a global 'geographic-like' molecular map ( Figure 1A ). ACSN has a hierarchical structure, composed of interconnected maps of biological process implicated in cancer. Each map is further divided into functional modules, corresponding mainly to canonical signalling pathways (Figure 1, 2C ). [12] ) .
The navigation interface include features such as scrolling, zooming, markers and callouts using Google Maps technology adapted by NaviCell [14] ( Figure 3 ), web-based platform supporting ACSN and similar efforts in CellDesigner format [15, 16] or other formats [17] . The semantic zooming in NaviCell (http://navicell.curie.fr), provides several view levels, achieved by gradual exclusion of details and abstraction of information upon zooming out ( Figure 2B ). ACSN is a unique resource of cancer signalling, with an enormous amount of information embedded and organized.
Together with NaviCell, it is optimized for integration and visualisation of cancer molecular profiles generated by high-throughput techniques, drug screening data or synthetic interactions studies. The integration and analysis of these data in the context of ACSN may help to better understand the biological significance of results, guiding scientific hypotheses and suggesting potential intervention points for cancer patients. In addition, since ACSN covers major cell signalling processes, the resource and associated methods for data analysis using ACSN are suitable for applications in many biological fields and for studying various human diseases.
The atlas is currently being extended with additional maps depicting molecular mechanisms of DNA replication, telomere maintenance, angiogenesis, immune response and others that will be integrated in future releases. The atlas will not only cover intracellular processes, but also cross talk of cancer cell with the components of tumour microenvironment. An additional level of complexity will be added to the atlas in near future, representing different types of cells surrounding tumour, and their interplay, to enable modelling of complex phenotypes.
Figure 4. General architecture of NaviCell Web service server
Client software (light blue layer) communicates with the server (red layer) through standard HTTP requests using the standard
JSON format to encode data (RESTful web service, dark blue layer). A session (with a unique ID) is established between the server and the browser (yellow layer) through Ajax communication channel to visualize the results of the commands send by
the software client (Adapted from [18] ).
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Data visualisation in NaviCell Web Service environment
The data integration into ACSN is possible using NaviCell Web Service, an user-friendly environment embedded into the NaviCell tool [18] . It allows uploading several types of "omics" data; e.g. expression data for mRNA, microRNA, proteins, mutation profiles, copy-number data, and visualize them simultaneously in the context of molecular interaction maps ( Figure 4 ).
Depending on the nature of the data, different types of visualisation modes can be required to achieve the informative picture maps, bar plots, glyphs and map staining ( Table 2 ). The data can be visualized at different zoom levels.
Sample annotation files uploaded with the data can serve to define groups of samples. Table 2 . Data display modes in NaviCell and NaviCom (Adapted from [19] ).
A novel mode of data visualisation for continuous data (e.g. expression) provided by NaviCell Web Service is the 'map staining'. In this technique, the values mapped to individual molecular entities or group of entities (e.g. score of functional module activities, see below), results in a colourful background of the network map that represents the data distribution pattern [18] . All those approaches for data integration into the signalling maps described above allow to rationalize the information embedded into the data: compare samples or group of samples; find typical patterns of data distribution across the molecular mechanisms depicted on the maps; grasp deregulated 'hot area' on the maps and major involved players and draw hypothesis as to which mechanisms to concentrate the work in the studied samples. These signalling network-based molecular signatures of samples thus help to stratify patients ( Figure 5 ). [12] ) .
Various omics data are available on the public and local databases [20] . However, there are no tools supporting the import of big datasets from these databases and display on signalling network maps in an efficient manner and with optimized visualisation settings. To answer to this demand, NaviCom has been developed, a python package and web interface for automatic simultaneous display of multi-level data in the context of signalling network map [19] .
NaviCom (http://navicom.curie.fr) is bridging between the cBioPortal database and the NaviCell interactive tool, for data visualisation NaviCom is empowered by a cBioFetchR R package to import high-throughput data sets from cBioPortal to NaviCell and Navicom Python module, permitting automatized simultaneous visualisation of multilevel omics data on the interactive signalling network maps using NaviCell environment ( Figure 6A ). NaviCom
proposes several standardized modes of data display on signalling networks maps to address specific biological questions ( Table 2 ).
Figure 6. General architecture of NaviCom environment
The NaviCom interface provides the user with an updated list of studies from cBioPortal and links to ACSN and NaviCell maps collections. When visualisation is launched, NaviCom starts a new NaviCell session and calls a cgi on the server. The cgi downloads cBioPortal data to the NaviCell session and displays them to generate the molecular portrait selected by the user.
(Adapted from [19] ) .
This tool enables generation of complex molecular portraits from multiple omics datasets from cBioPortal. In near future the NaviCom platform will be extended and will provide access to any type of omics data from a wide range of databases (TCGA, ICGC, HGMB, METABRIC, CCLE). In addition, to allow broader description of molecular mechanisms implicated in the studied sample, signalling networks available in databases as KEGG [21] , Reactome [22] and others, will be also integrated and used for high-throughput data analysis via NaviCom platform.
Data analysis using ACSN
To identify enriched modules of a molecular map from a given dataset, several tools are currently available. Gene
Set Enrichment Analysis (GSEA) (http://software.broadinstitute.org/gsea/index.jsp) is a computational method aimed to find over-represented modules in a ranked gene list, using a weighted Kolmogorov-Smirnov test [23] .
ACSNMineR (https://github.com/sysbio-curie/ACSNMineR) is an R package that incorporates ACSN information whereas it has low expression in invasive bladder tumours. Strikingly, the best intervention for Ta tumours consists of the disruption of both p38 and a downstream target of PI3K (i.e. AKT).
In the most invasive T2, T3 and T4 stages of bladder cancer there are three up-regulated functional modules, all characterised by high expression of RTK/ERK signalling components ( Figure 8B ; stages T2, T3 and T4). OCSANA results ( Table 3 ) point to the de-phosphorylation of both ERK and RAS as best interventions to block proliferation, which makes it coherent the current developments of RAS-and ERK-inhibiting drugs for several cancer types, including bladder cancer [43] . Table 3 . Intervention sets for stage-specific activated modules in bladder cancer (Adapted from [39] ) .
The analysis suggested different interventions depending on tumour stage. In less invasive tumours p38 coupled with PI3K-dependent signalling could be targeted, whereas RAS/ERK pathway is likely more critical for more invasive stages. Similarly, network analysis using ACSN and OCSANA can be performed for individual patient tumour profiles, leading to personalized recommendations of treatment [44] .
Finding metastasis inducers in colon cancer through network analysis
Evolution of invasion and metastasis, in particular in colon cancer, has been studied in experimental models, however, the mechanism that triggers the process is still not clear and the available mice models of colon cancer are far from being satisfactory [45] [46] . With the aim to create an experimental mouse model of invasive colon cancer, one needs to address the question what are the major players and the driver mutations inducing invasion. One of early events of metastasis is assumed to be epithelial to mesenchymal transition (EMT) [47] . In order to identify the interplay between signalling pathways regulating EMT, a signalling network was manually created based on the information retrieved from around 200 publications. This signalling map is integrated into the To validate this hypothesis, a transgenic mouse model was generated, expressing a constitutively active Notch1 receptor in a p53-deleted background, specifically in the digestive epithelium. Importantly, green fluorescent protein (GFP) expression linked to the Notch1 receptor activation allows lineage tracing of epithelial tumour cells during cancer progression and invasion ( Figure 10A ). These mice develop digestive tumours with dissemination of EMTlike epithelial malignant cells to the lymph nodes, liver and peritoneum and generation of distant metastases ( Figure   10B ). Exploration of early EMT program inducers in in invasive human colon cancer samples confirmed that EMT markers are associated with modulation of Notch and p53 gene expression in similar manner as in the mice model ( Figure 10C) , supporting a synergy between these genes to permit EMT induction [53] .
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Figure 10. p53 loss -Notch (NICD) overexpression double mutant results in invasive phenotype in colon cancer mice
Immunostaining for major EMT marker in (A) primary tumour and (B) metastases in distant organs; (C) Regulation of p53,
Notch and Wnt pathways in invasive colon cancer in human (TCGA data). (Adapted from [53] ) .
The prediction of synthetic interaction between Notch (NICD) and p53 demonstrated that there are alternative ways to reach permissive conditions to induce EMT, in addition to those already described in the literature. This idea was not intuitive and actually contradictory to the commonly accepted dogma in the colon cancer field. The study evokes an important message that gathering cell signalling mechanisms together may undercover un-expected interactions and lead to discovery of new mechanisms in regulation of cell phenotypes that may significantly affect the understanding of basic molecular processes implicated in cancer and change the therapeutic approaches. In addition, the comprehensive EMT signalling network is rich resource of information can be used in further studies. Finally, the new EMT mice is a relevant model mimicking the invasive human colon cancer and a system for therapeutic drugs discovery [54] .
Finding susceptibility to papillary thyroid carcinoma development
Modules and maps of ACSN can serve as signatures of biological functions and can be used to find association between perturbations in particular molecular mechanisms to the risk of a specific cancer type development. In 
Conclusions
This review is devoted to the use of signalling network modelling in cancer research, and exemplified with the multidisciplinary project Atlas of Cancer Signalling Network (ACSN). It described approaches addressing complexity of cancer by systematic representation of signalling implicated in the disease in the form of comprehensive signalling network maps and tools for network-based analysis, and visualisation and interpretation of cancer omics data. It summarized several studies on application of ACSN for finding synthetically interacting genes in cancer; predicting drug synergy; suggesting complex intervention sets and associating molecular mechanisms to cancer development susceptibility. These examples can serve as a basis for a more generalised approach. A fundamental question of signalling regulation in human disorders can be addressed by experimental and computational approaches, helping together to understand the principles of signalling rewiring [1] . It will have an impact on personalized intervention schemes, in particular those based on pharmacological combination.
Organisation and formal representation of the knowledge of cell signalling followed by analysis of network features is a general paradigm that provides a more global view on molecular mechanisms and facilitates modelling of cell fates. It has a potential to explain mutant phenotypes, and reveal new molecular interactions. Considering the topology of signalling networks and studying network perturbations together with high-throughput data can guide toward an optimal therapeutic strategy in patients or in studied experimental systems, providing both new intervention points and relevant biomarkers.
Figure11. Approaches for comprehensive cell signalling network maps applications together with high-throughput data
Approach can be useful for analysing perturbations in cellular processes and proposing synthetic combinations in research and in clinics: systematically represent molecular processes as comprehensive signalling networks, retrieve principles of signalling coordination and synthetic interactions, interpret omics data from disease in the context of signalling network, find signalling network fragilities in the disease, predict sensitivity to drug, suggest intervention hits.
There is ongoing effort to include ACSN content into aggregated pathway databases such as Pathway Commons [56] and WikiPathways [57] such that it can be used in many projects through standard interfaces as Cytoscape [58] .
In addition, the approach adopted in ACSN projects has a wide potential, applicable for other complex diseases.
This rationale has led to the creation of a collective research effort on different human disorders called Disease Maps project (http://disease-maps.org). This partnership aims at applying similar approaches as described in this review, that will lead to identification of emerging disease hallmarks. This will help to study diseases comorbidity, predict response to standard treatments and to suggest improved individual intervention schemes based on drug repositioning [6] .
Five key points summary 1 . ACSN is a resource of cancer signalling knowledge, comprehensive map of molecular interactions in cancer based on the latest scientific literature.
2. NaviCell and NaviCom are interactive web-based environment for molecular maps navigation omics data integration and visualisation.
3. Interpretation of omics data from breast cancer cell lines with different sensitivity to targeted drugs in the context of signalling network to retrieve deregulated functional modules and to suggest synergy between drugs.
4.
Application of signalling maps to find network fragilities in bladder cancer and to suggest intervention sets using OCSANA algorithm.
5. Prediction of non-intuitive combination of synthetically interacting genes in colon cancer using network analysis, formulating hypothesis on molecular mechanism and development of mice model.
